ImportRefusal LogoImportRefusal

Nagina Fazal

⚠️ Moderate Risk

FEI: 3005063380 • Bangalore, Karnataka • INDIA

FEI

FEI Number

3005063380

📍

Location

Bangalore, Karnataka

🇮🇳

Country

INDIA
🏢

Address

No 11, , Bangalore, Karnataka, India

Moderate Risk

FDA Import Risk Assessment

40.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
3
Unique Violations
4/21/2005
Latest Refusal
4/21/2005
Earliest Refusal

Score Breakdown

Violation Severity
66.7×40%
Refusal Volume
28.8×30%
Recency
0.0×20%
Frequency
50.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

754×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

23001×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

Refusal History

DateProductViolationsDivision
4/21/2005
54BGA15CHROMIUM (MINERAL)
2300DIETARYLBL
New York District Office (NYK-DO)
4/21/2005
65RDA01CALCIUM CHLORIDE (REPLENISHER)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
4/21/2005
61PDA26METFORMIN (ANTI-DIABETIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
4/21/2005
61PDA26METFORMIN (ANTI-DIABETIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
4/21/2005
62OCA41LOSARTAN POTASSIUM (ANTI-HYPERTENSIVE - PART II)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)

Frequently Asked Questions

What is Nagina Fazal's FDA import refusal history?

Nagina Fazal (FEI: 3005063380) has 5 FDA import refusal record(s) in our database, spanning from 4/21/2005 to 4/21/2005.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Nagina Fazal's FEI number is 3005063380.

What types of violations has Nagina Fazal received?

Nagina Fazal has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Nagina Fazal come from?

All FDA import refusal data for Nagina Fazal is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.